Harpreet Singh Bajaj, MD, MPH, ECNU, FACE
Endocrinologist and Epidemiologist, LMC Diabetes & Endocrinology, Brampton, ON
Research Associate, Leadership Sinai Centre for Diabetes, Mount Sinai Hospital, Toronto
Co-Chair, Marketing & Communication, Diabetes Canada National Professional Section
Columnist and blogger, www.medscape.com
Founder, “STOP Diabetes” Foundation Inc.
Harpreet Singh Bajaj started his Endocrinology specialty clinical practice in Brampton in 2009 after completing his clinical fellowship at the Cleveland Clinic (Ohio, USA). Dr. Bajaj’s medical education was at Maulana Azad Medical College (New Delhi, India), following which he attained a Masters of Public Health (MPH, major in Epidemiology) at State University of New York in Albany (New York, USA).
Dr. Bajaj is a Research Associate at Mount Sinai Hospital, Toronto and an adjunct lecturer at McMaster University. He has co-authored publications in key medical journals in the fields of diabetes, obesity and cardiovascular risk assessment. His major interest lies in translational research focused on “real-life” practical approaches to improve standards of clinical practice for diabetes and cardiovascular risk factors.
He volunteers with numerous community public health as well as media programs with the intent of raising public awareness on diabetes prevention and treatment, with a specific focus on the South Asian origin population in Canada. He is the founder of STOP Diabetes Foundation, a registered charitable organization, working to reduce the burden of diabetes in Peel region of Ontario.
Dr. Bajaj serves Diabetes Canada (formerly CDA) as a co-chair of the Communications and Marketing portfolio within the professional section national executive, as a national consultant editor for the Canadian Journal for Diabetes and as an expert committee member for the 2018 Clinical Practice Guidelines.